Table 2 Osteoporosis treatment during first year and first 2 years of follow-up of 218 patients with rheumatoid arthritis
Sequential monotherapy (group 1)(n = 55)Step-up combination therapy (group 2)(n = 46)Initial combination with prednisone (group 3)(n = 65)Initial combination with infliximab (group 4)(n = 52)
Bisphosphonates use, % (n = 218)79294
15173215
No. of months used during follow-up*9 (7–11)8 (4–9)9 (6–9)9 (6–12)
11 (7–12)12 (5–12)10 (9–12)9 (6–12)
Calcium supplements, % (n = 218)20204319
22304631
No. of months used during follow-up*9 (6–12)9 (2–11)9 (8–11)9 (8–12)
12 (12–12)12 (11–12)12 (6–12)12 (10–12)
Vitamin D supplements, % (n = 218)6152210
11222212
No. of months used during follow-up*6 (6–12)9 (6–9)9 (5–9)9 (8–11)
6 (3–12)12 (11–12)12 (8–12)12 (11–12)
HRT use, % (n = 213)1515815
1514819
No. of years used*9 (3–17)15 (2–19)5 (4–17)6 (2–16)
9 (4–19)14 (4–21)7 (5–19)7 (2–16)
Intra-articular steroids injections3317810
(min 1–max 6), % (n = 218)134126
  • HRT, hormone replacement therapy.

  • *Median (interquartile range).